Health Care
Lawsuit filed over denial of senior's home care
February 8, 2012
IBJ Staff and Associated PressA Carmel-based health insurer once owned by Conseco Inc. is being sued for refusing to pay claims for in-home care submitted
by California senior citizens.
MoreDrugmakers singing same song: 2012 will be tough
February 2, 2012
Associated PressFor drugmakers, the golden era of the 1990s and early part of the last decade, when they seemed to effortlessly churn out
new multibillion-dollar pills for the masses along with double-digit quarterly profit increases, is not even in the rearview
mirror any more.
MoreLilly eying deal with Turkish drug company
January 31, 2012
Bloomberg NewsEli Lilly and Co. is among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in
a deal that may value the Turkish drugmaker at $1 billion, sources say.
MoreCommunity agrees to absorb Howard Regional
January 31, 2012
J.K. WallKokomo’s Howard Regional Health System has signed a letter of intent to join the Community Health Network less than
four months after it broke off a merger deal with Indiana University Health.
MoreGallagher sees more broker mergers coming
January 30, 2012
J.K. WallThe Carmel office of Arthur J. Gallagher & Co. just made its sixth acquisition in five years, and it expects looming changes
to tax and health laws to produce even more chances to snap up benefits brokers this year.
MoreLilly's ex-partner wins FDA approval for diabetes drug
January 29, 2012
Bloomberg NewsAmylin Pharmaceuticals Inc. and Alkermes Plc have gained U.S. clearance for Bydureon, a once-weekly diabetes shot. Eli Lilly
and Co. co-developed the drug, but ended its partnership with Amylin last year.
MoreUPDATE: WellPoint to boost primary-care pay
January 27, 2012
Associated PressHealth insurer WellPoint Inc. plans to improve primary care reimbursement and start paying for care management it doesn't
currently cover, changes that could give patients more quality time with their doctors.
MoreIndiana House backs broader ban on synthetic drugs
January 26, 2012
Associated PressThe Indiana House has approved a bill that would broaden the state's ban on synthetic drugs to include compounds nicknamed
"bath salts" and others that mimic marijuana.
MoreWellPoint earnings fall well short of analysts' expectations
January 25, 2012
J.K. WallThe Indianapolis-based health insurer reported earnings of $335.3 million, or 96 cents per share, down 39 percent from the
same quarter a year ago.
MoreEli Lilly unit plans to buy feed-enzyme maker
January 24, 2012
Associated PressDrugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products
that improve poultry, egg and meat production.
MoreDeal with Walgreen perplexes Arcadia's investors
January 21, 2012
J.K. WallSomething doesn’t add up about Arcadia Resources Inc.’s agreement to sell its pharmacy business for a low price
of $2 million, according to many of the Indianapolis company’s investors.
MoreFrench breast-implant recall could sway U.S. device debate
January 19, 2012
Bloomberg NewsU.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like
their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
MoreRating doctors and other health care providers
January 14, 2012
Sam StallA new onslaught of Medicare data might shine more light on providers, but tricky questions abound.
MoreLilly's Zyprexa pact with health providers wins approval
January 12, 2012
Bloomberg NewsEli Lilly and Co. has won approval of a $4.5 million settlement with five union health funds and an insurer that alleged improper
marketing of the company's best-selling medication, Zyprexa, raised their costs.
MoreOnce-rising star AIT Laboratories now cutting jobs
January 11, 2012
Chris O'MalleyAIT Laboratories, one of the area’s fastest-growing companies in recent years, confirmed Tuesday that it is eliminating
jobs, but would not say how many. The company said it is restructuring.
MoreDrugmaker plans 234 Terre Haute jobs by 2016
January 10, 2012
IBJ Staff and Associated PressA California-based pharmaceutical company says it expects to hire 234 people by 2016 at a new operation on the site of a former
Pfizer Inc. drug plant near Terre Haute.
MorePressure rises as Lilly tries squeeze play
January 9, 2012
J.K. WallIndianapolis-based Eli Lilly and Co. is now in the predicament of watching revenue fall as its patents on older products expire,
even as the company needs to spend more money on marketing and research to boost sales of new drugs.
MoreBoston lawsuit claims DES-breast cancer link
January 8, 2012
Associated PressFifty-three women from around the country are suing drug companies, including Eli Lilly and Co., who made and promoted DES
for millions of pregnant women from about 1938 to the early 1970s.
MoreHealthx receives $22M capital infusion
January 6, 2012
Frontier Capital in Charlotte, N.C., provided the funding that will support the continued expansion of Healthx, a local provider
of online health care portals.
MoreLilly's 2012 earnings forecast misses analyst estimates
January 5, 2012
Bloomberg News, Associated PressIndianapolis-based Eli Lilly and Co. provided a 2012 earnings forecast Thursday morning that missed analyst estimates by a
wide margin, sending shares down.
MoreLilly challenging Biogen patent in London lawsuit
January 5, 2012
Bloomberg NewsEli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system
diseases.
MoreWellPoint, other insurers profit from health law they oppose
January 5, 2012
Insurance companies spent millions of dollars trying to defeat the U.S. health-care overhaul. But profit margins at the companies
have widened to levels not seen since before the recession, a Bloomberg Government study shows.
MoreEndocyte stays course despite being battered by investors
December 31, 2011
J.K. WallAfter spending most of 2011 as a Wall Street darling, the year ended ugly for Endocyte Inc. But CEO Ron Ellis thinks the West
Lafayette-based drug developer is in better position than ever.
MoreLilly losing dominance in diabetes treatment
December 31, 2011
J.K. WallEli Lilly and Co., after more than a decade of setbacks, is counting on diabetes to help it survive a string of patent losses
on other products that have begun to sap the drugmaker's sales.
MoreWalgreen expects to lose most Express Scripts biz
December 29, 2011
Associated PressDrugstore operator Walgreen Co. said Thursday it expects to lose almost 90 percent of prescriptions handled by pharmacy benefits
manager Express Scripts Inc. after it leaves Express Scripts' networks on Jan. 1.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
IBJ Featured Advertisers
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Members must realize if you stop paying your dues you will lose. Why else would your employer honor the rtw bill. Before you take this step think about what you may be giving up in the long run. Very little of your dues money goes to any dem candidate. YOu will never know how much your republican employer gives his party with money he could be paying the employee. Who will step up and demand better wages or benefits if you have no representation. Union is the way for a better life. Our carpenter union offers a 4 year apprenticeship and 2 year degree from Ivy Tech all paid for with union dues . This is a great opportunity for kids who cant afford schooling after high school. The same opportunity is there for any person,any age, either sex to provide a better living for their family. Pension, anuity, health insurance all for your dues. How is this a bad choice.
The FDIC is funded by assessments paid by banks, not taxpayers. That is not to say that bank customers don't ultimately pay the cost because, in the end, banks don't survive if they don't make profits.
SCB Bank's failure is expected to cost the government $33.9 million,dont you mean middle class another bailout our government has no money
Diogenes, the company did not call "pro-life" statements inflammatory. The IBJ article used the words "pro life."
All, the company did, is what it should do which is apologize profusely for offending people with a program that offered statements that support an infamous apartheid proponent, Dr. Verwoerd, suggest that sometimes rape is justified, and quote Biblical text to people, not looking for it.
If this is what you think is "insanity" then more companies need to behave insanely.
I totally disagree with $45mil being given to the state Attorney General's office. That money is a waste. All of the money should go to help the homeowners & the people who were foreclosed on. Why such a big percentage to state govt? They'll get to start another agency staffed with people who have new-found power & don't care about the people they serve. As soon as the program was announced, I knew the states would end up with a huge chunk of the money for themselves that would just be squandered. Or maybe Mitch Daniels will just happen to "find" another big chunk of money that was "posted in the wrong section of the state's books."